Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020;16(2):445-451.
doi: 10.1080/21645515.2019.1656021. Epub 2019 Sep 5.

Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey

Affiliations

Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey

Ahmet Soysal et al. Hum Vaccin Immunother. 2020.

Abstract

The aim of this study was to investigate changes in the incidences of acute otitis media (AOM), recurrent AOM (rAOM) and tympanostomy tube (TT) insertion in children following the introduction of 13-valent pneumococcal conjugate vaccine (PCV13) into the national immunization program (NIP) of Turkey in April 2011. National coverage for the PCV7 was 97% in 2009, 93% in 2010, 96% in 2011 and for the PVC13 was 97% in 2012, 97% in 2013, 96% in 2014, 97% in 2015, 98% in 2016, and 96% in 2017 for Turkish children younger than 12 months of age. A total of 499932 pediatric visits were recorded, and AOM was diagnosed in 23005 (4.6%) children. The incidence of AOM in children ≤5 years of age decreased from 10700/100000 (2011) to 4712/100000 (2017), with a significant decreasing trend (p < .001, r = -0.965). When the mean annual incidences of AOM between the transition period of PCV13 (years 2011/2012) were compared with those of a post-PCV13 period (years 2016/2017) for children ≤5 years of age, the incidence of AOM was found to be decreased by 54% (p = 0.013). The mean incidence of TT insertion was found to be decreased by 65% (p = 0.003) between the transition period of PCV13 and a post-PCV13 period for children ≤5 years of age. On the other hand, rAOM incidence was found to be increased in whole pediatric age groups. Our study showed a significant decrease in the incidences of AOM and TT insertion in children ≤5 years old after implementation of PCV13 in the NIP in Turkey.

Keywords: Pneumococcal conjugate vaccine; acute otitis media; incidence of otitis media; recurrent acute otitis media; tympanostomy tube.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Trends in incidence of Acute Otitis Media with respect to age groups and years.
Figure 2.
Figure 2.
Trends in incidence of Recurrent Acute Otitis Media with respect to age groups and years.
Figure 3.
Figure 3.
Trends in incidence of Tympanostomy Tube insertion with respect to age groups and years.

References

    1. Coker TR, Chan LS, Newberry SJ, Limbos MA, Suttorp MJ, Shekelle PG, Takata GS.. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA. 2010;304:2161. doi: 10.1001/jama.2010.1651. - DOI - PubMed
    1. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279:875. doi: 10.1001/jama.279.11.875. - DOI - PubMed
    1. Skinner JM, Indrawati L, Cannon J, Blue J, Winters M, Macnair J, Pujar N, Manger W, Zhang Y, Antonello J, et al. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15- CRM197) in an infant-rhesus monkey immunogenicity model. Vaccine. 2011;29:8870–76. doi: 10.1016/j.vaccine.2011.09.078. - DOI - PubMed
    1. Bluestone CD. Clinical course, complications and sequelae of acute otitis media. Pediatr Infect Dis J. 2000;19(5 Suppl):S37. doi: 10.1097/00006454-200005001-00007. - DOI - PubMed
    1. Ceyhan M. Konjuge Pnömokok Aşılarında Son Gelişmeler: 13-Valanlı Konjuge Pnömokok Aşısı. J Pediatr Inf. 2011;5:68–73. doi: 10.5152/ced.2011.25. - DOI